NCT02010801View on ClinicalTrials.gov

Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Malignant Liver Tumors
Interventions
PROCEDURE

irreversible electroporation

DEVICE

nanoknife AngioDynamics US Ltd

Trial Locations (1)

10002

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT02010801 - Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors | Biotech Hunter | Biotech Hunter